These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interactions of pyrrolobenzodiazepine dimers and duplex DNA from methicillin-resistant Staphylococcus aureus. Hadjivassileva T; Stapleton PD; Thurston DE; Taylor PW Int J Antimicrob Agents; 2007 Jun; 29(6):672-8. PubMed ID: 17350809 [TBL] [Abstract][Full Text] [Related]
3. Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8' ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers. Gregson SJ; Howard PW; Gullick DR; Hamaguchi A; Corcoran KE; Brooks NA; Hartley JA; Jenkins TC; Patel S; Guille MJ; Thurston DE J Med Chem; 2004 Feb; 47(5):1161-74. PubMed ID: 14971896 [TBL] [Abstract][Full Text] [Related]
4. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives. Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725 [TBL] [Abstract][Full Text] [Related]
5. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers. Griffin JH; Linsell MS; Nodwell MB; Chen Q; Pace JL; Quast KL; Krause KM; Farrington L; Wu TX; Higgins DL; Jenkins TE; Christensen BG; Judice JK J Am Chem Soc; 2003 May; 125(21):6517-31. PubMed ID: 12785792 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility studies of piperazinyl-cross-linked fluoroquinolone dimers against test strains of Gram-positive and Gram-negative bacteria. Kerns RJ; Rybak MJ; Cheung CM Diagn Microbiol Infect Dis; 2006 Apr; 54(4):305-10. PubMed ID: 16466892 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species. Farrell DJ; Robbins M; Rhys-Williams W; Love WG Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres. Gales AC; Sader HS; Jones RN Clin Microbiol Infect; 2005 Feb; 11(2):95-100. PubMed ID: 15679482 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004). Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [TBL] [Abstract][Full Text] [Related]
11. DNA binding ligands targeting drug-resistant bacteria: structure, activity, and pharmacology. Kaizerman JA; Gross MI; Ge Y; White S; Hu W; Duan JX; Baird EE; Johnson KW; Tanaka RD; Moser HE; Bürli RW J Med Chem; 2003 Aug; 46(18):3914-29. PubMed ID: 12930152 [TBL] [Abstract][Full Text] [Related]
12. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy. Roveta S; Marchese A; Debbia EA Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative. Draghi DC; Benton BM; Krause KM; Thornsberry C; Pillar C; Sahm DF J Antimicrob Chemother; 2008 Jul; 62(1):116-21. PubMed ID: 18424792 [TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis. Alhanout K; Brunel JM; Raoult D; Rolain JM J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647 [TBL] [Abstract][Full Text] [Related]
15. Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia. Morrissey I; Ge Y; Janes R Int J Antimicrob Agents; 2009 Jun; 33(6):515-9. PubMed ID: 19203863 [TBL] [Abstract][Full Text] [Related]
16. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity. Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986 [TBL] [Abstract][Full Text] [Related]
17. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004). Fritsche TR; Sader HS; Jones RN Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139 [TBL] [Abstract][Full Text] [Related]
18. An asymmetric C8/C8'-tripyrrole-linked sequence-selective pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimer DNA interstrand cross-linking agent spanning 11 DNA base pairs. Tiberghien AC; Evans DA; Kiakos K; Martin CR; Hartley JA; Thurston DE; Howard PW Bioorg Med Chem Lett; 2008 Mar; 18(6):2073-7. PubMed ID: 18272367 [TBL] [Abstract][Full Text] [Related]
19. Sequence-selective recognition of duplex DNA through covalent interstrand cross-linking: kinetic and molecular modeling studies with pyrrolobenzodiazepine dimers. Smellie M; Bose DS; Thompson AS; Jenkins TC; Hartley JA; Thurston DE Biochemistry; 2003 Jul; 42(27):8232-9. PubMed ID: 12846572 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Garrison MW; Nuemiller JJ Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]